Evaluation of PET/MRI in Children With Cancer
Sponsor: Massachusetts General Hospital
This NA trial investigates Hematologic Malignancy and is currently completed. Massachusetts General Hospital leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
-
Mar 2025 — Jun 2025 [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2024 — Mar 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Oct 2021 — Sep 2023 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status NA
-
Mar 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .